Similarly, our data still showed that DNMT3A mutations had a significant association with NPM1, FLT3‐ITD, and IDH1/IDH2 mutations, and but an inverse correlation with CEBPA mutations in CN‐AML patients. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.